Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,228,840
+$77,035 QoQ
Shares Held
8,776
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#2,256
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SYM FINANCIAL Corp holds $16,389,932 across 11 Drug Manufacturers - General names. JNJ ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,406 | $8,882,979 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
8,776 | $2,228,840 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,324 | $1,069,634 | |
| 4 | ABBV |
AbbVie Inc.
|
4,148 | $1,043,802 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,012 | $807,371 | |
| 6 | NVS |
Novartis AG
|
3,984 | $624,372 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,465 | $437,768 | |
| 8 | PFE |
Pfizer Inc
|
16,120 | $388,169 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,228,840 | 8,776 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,151,805 | 8,803 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,782,046 | 8,611 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,653,575 | 8,918 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,315,483 | 8,612 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,585,264 | 9,559 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,164,191 | 8,050 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,124,210 | 6,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $996,080 | 6,815 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $741,752 | 4,689 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $934,640 | 5,963 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $806,162 | 5,176 | Shares | Sole | 2023-10-27 | |
| 2023-03-31 | $270,940 | 1,748 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $462,469 | 2,618 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $427,676 | 2,618 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $469,868 | 2,647 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $456,190 | 2,574 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $434,175 | 2,538 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $516,477 | 3,198 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $479,063 | 2,908 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $298,295 | 1,815 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $272,110 | 1,729 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $248,182 | 1,667 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $232,883 | 1,656 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $242,459 | 1,849 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||